Related Experiment Videos
Endothelin receptor blockade improves endothelial function in human internal mammary arteries
S Verma1, F Lovren, A S Dumont
1Faculty of Medicine, The University of Calgary, Calgary, Canada.
Cardiovascular Research
|December 21, 2000
Summary
Endothelin-1 receptor blockade improves vasodilation in human internal mammary arteries. Blocking endothelin-1 receptors (ET(A) and ET(B)) enhances acetylcholine-induced relaxation, suggesting a therapeutic role in endothelial dysfunction.
Area of Science:
- Cardiovascular Research
- Vascular Biology
- Pharmacology
Background:
- Endothelial dysfunction contributes to vasospasm, with endothelin-1 (ET-1) a key vasoconstrictor.
- The role of ET-1 in human internal mammary artery (IMA) endothelial dysfunction requires further investigation.
Purpose of the Study:
- To evaluate the role of ET-1 in endothelial dysfunction in human IMA.
- To assess the impact of ET receptor antagonists on endothelial function in IMA.
Main Methods:
- Human IMA segments from 51 CABG patients were used for in vitro studies.
- Acetylcholine (ACh)-induced vasodilation and sodium nitroprusside (SNP)-induced relaxation were measured.
- Dose-response curves were generated with and without ET receptor antagonists (bosentan, BQ-123, BQ-788).
Main Results:
- ACh induced dose-dependent relaxation in IMA.
- ET receptor antagonists (bosentan, BQ-123, BQ-788) significantly augmented ACh-induced relaxation.
- These beneficial effects were endothelium-specific and mediated by both ET(A) and ET(B) receptors.
Conclusions:
- ET receptor blockade demonstrates beneficial effects on endothelial-dependent vasorelaxation in human IMA.
- This study provides novel insights into the therapeutic potential of ET receptor antagonists for IMA endothelial dysfunction.